Pure-EncapsulationsSudbury, MA, April 3, 2014 – Pure Encapsulations®, a leading manufacturer of research-based, hypo-allergenic nutritional supplements, announces the expansion of its PureHeart™ initiative with a new strategic partner and innovative daily packet. The PureHeart™ initiative aligns Pure Encapsulations’ research-based, cardiometabolic supplements with strategic partners to provide healthcare professionals with a full-service, personalized healthcare platform — Screening + Supplements = Success™.*

Pure-EncapsulationsFull-service, personalized, cardiometabolic healthcare platform 

Sudbury, MA, April 3, 2014 – Pure Encapsulations®, a leading manufacturer of research-based, hypo-allergenic nutritional supplements, announces the expansion of its PureHeart™ initiative with a new strategic partner and innovative daily packet. The PureHeart™ initiative aligns Pure Encapsulations’ research-based, cardiometabolic supplements with strategic partners to provide healthcare professionals with a full-service, personalized healthcare platform — Screening + Supplements = Success™.* 

“We announced our newest PureHeart™ partner—Boston Heart Diagnostics Corporation—at The Institute for Functional Medicine (IFM) Cardiometabolic conference in Boston,” stated Joy Devins, Vice President, at Pure Encapsulations. “We were proud to have as our guest speaker Michael Dansinger, MD, professor at Tufts University and Medical Director for Boston Heart Diagnostics, who discussed their proprietary biomarker solutions, including HDL Map™ and Cholesterol Balance Test™, along with the Boston Heart Lifestyle Program.”

Along with the new partnership, the latest addition to the PureHeart™ line of nutritional supplements is PureHeart™ Pure Pack, a daily packet featuring a comprehensive blend of vitamins, minerals, CoQ10, antioxidants and essential fatty acids designed to support arterial and overall cardiovascular health.* 

“PureHeart™ Pure Pack also includes a unique polyphenol combination, PhytoCardio,” stated Kelly Heim, Ph.D., Nutritional Pharmacologist, at Pure Encapsulations. “This proprietary blend of blueberry and cranberry fruit extracts was developed as part of a comprehensive research program with the Institute of Nutrition and Functional Foods (INAF) based at Université Laval, Quebec, Canada.” 

In addition to Pure Encapsulations’ newest partner, Boston Heart Diagnostics Corporation and founding partner Cleveland HeartLab, PureHeart™ has expanded to include Bariatric and Oral Systemic specialists, as well as SilverStaff Clinical Laboratories. 

“Pure is excited to help lead the personalized medicine movement through innovation, research, education, and through the partnerships we have developed with these leading biomarker and genetic testing experts,” Devins concluded. 

For more information about PureHeart™ Pure Pack, Boston Heart Diagnostics, or additional details regarding PureHeart™, please visit www.PureHeartProtocol.com, or contactBryanna Charbonneau at bcharbonneau@PureEncapsulations.com.

About Pure Encapsulations®
A business unit of Atrium Innovations Inc., Pure Encapsulations® is committed to producing a complete line of research-based nutritional supplements. Available through health professionals, finished products are pure and hypo-allergenic to optimize the long-term health of the most sensitive patients.* Pure Encapsulations® is an industry leader in quality, with an extensive raw material and finished product testing program that includes analysis for identity, potency, environmental contaminants, oxidation and more by certified third party laboratories. Pure Encapsulations® is NSF-GMP registered in the U.S., MP certified in Canada and exceeds the standards of the United States Pharmacopeia (USP) for supplement manufacturing. For additional information, please visit www.PureEncapsulations.com

About PureHeart™
PureHeart™ is a framework of strategic partnerships that will advance cardiometabolic care “beyond lipids.”  Since half of all individuals faced with a cardiovascular event had normal values on their standard lipid panel, PureHeart™ aims to raise awareness on underlying factors, beginning with oral health and ending with the health of the artery wall. Our partners in advanced biomarker and genetic testing will empower physicians with personalized medicine. Our integrative specialists, including lipidologists, bariatric physicians, and oral systemic health professionals will offer education and expertise. Evidence-based, cardiometabolic dietary supplements developed in conjunction with our research partner will provide co-support options for the new paradigm in cardio-metabolic medicine, focused on a personalized approach for improved patient outcomes.*

About Atrium Innovations
Atrium Innovations Inc. is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products which are distributed in more than 35 countries.  The Company owns healthcare practitioner and specialized retail product brands that are at the forefront of science, innovation and education.  Atrium has over 1,300 employees and operates seven manufacturing facilities complying with current Good Manufacturing Practices. Additional information is available at www.atrium-innovations.com

Media Contacts:  
Primary:
Bryanna Charbonneau
Pure Encapsulations

p: 800-753-2277
e: bcharbonneau@PureEncapsulations.com  

Other:
Amelie Germain
Atrium Innovations
p: 418-652-1116
e: ag@atrium-innovations.com 

Darice Case
Chemistry Communications
p: 412-325-2895
e: darice@visitthelab.com 

###

 *These statements have not been evaluated by the Food & Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.